İstatistikler

Akademik İstatistikler

Yıllara ve indekslere göre yayın & atıf dağılımı

Son 10 Yıla Göre Atıf Sayısı

İndekse Göre Atıf Sayısı

İndekse Göre Makale Sayısı

Yıllara Göre Yayın Dağılımı

Yayın ve Akademik Faaliyet Özeti

Makale

Atıf

Bildiri

Ödül

Tez

İndekslere Göre Yayın Sayıları

4 indeks

SCI-E

Diğer

TR Dizin

ESCI

Makale Bilgileri

Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer, Scientific Reports, 15(0), 2025 SCI / SCI EXPANDED

Yasin Sezgin, Oğur Karhan, Mehmet Naci Aldemir, Muslih Ürün, Berrak Mermit Erçek

The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis, BMC CANCER, 25(0), 2025 SCI / SCI EXPANDED

Sedat Yıldırım, Tugba Başoğlu, Akif Doğan, Goncagul Akdağ, Oguzcan Kınıkoğlu

Importance of hematological and inflammatory markers in the localization of gastric cancer, World Journal of Gastrointestinal Oncology, 17(4), 2025 SCI / SCI EXPANDED

Süleyman Dolu, Mehmet Barış Cengiz, Hüseyin Döngelli, Doç. Dr. Mustafa Gürbüz, Mehmet Emin Arayıcı

Prognostic Value of Metabolic Tumor Volume and Heterogeneity Index in Diffuse Large B-Cell Lymphoma, Medicina-Lithuania, 61(0), 2025 SCI / SCI EXPANDED

Ali Alper Solmaz, Ilhan Birsenogul, Aygul Polat Kelle, Pinar Peker, Burcu Arslan Benli

The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing, JOURNAL OF CHEMOTHERAPY, 36(0), 2024 SCI / SCI EXPANDED

Osman Köstek, Ahmet Demirel, Muhammet Bekir Hacıoğlu, Didem Tastekin, Senem Karabulut

Rectal Cancer and Lateral Lymph Node Staging: Interobserver Agreement and Success in Predicting Locoregional Recurrence, Diagnostics, 14(22), 2024 SCI / SCI EXPANDED

Hüseyin Akkaya, Okan Dilek, Selim Özdemir, Turgay Öztürkçü, Doç. Dr. Mustafa Gürbüz

Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer, Journal of Cancer Research and Therapeutics, 19(0), 2023 SCI / SCI EXPANDED

İzzet Doğan, Doç. Dr. Mustafa Gürbüz, Esra Aydın, Senem Karabulut, Didem Taştekin

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers, Balkan Journal of Medical Genetics, 25(0), 2023 SCI / SCI EXPANDED

Osman Köstek, Ahmet Küçükarda, Hilmi Tozkır, İlker Nihat Ökten, Ercan Özden

Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148(0), 2022 SCI / SCI EXPANDED

Doç. Dr. Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş, Elif Berna Köksoy, Naziyet Köse

The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study, MEDICINE, 101(0), 2022 SCI / SCI EXPANDED

İzzet Doğan, Murat Ayhan, Doç. Dr. Mustafa Gürbüz, Ahmet Kucukarda, Esra Aydın

Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group, MEDICINE, 101(50), 2022 SCI / SCI EXPANDED

Doç. Dr. Mustafa Gürbüz, Saadettin Kılıçkap, Ahmet Bilici, Nuri Karadurmuş, Ahmet Sezer

Clinicopathological Factors in Relation to HER2 Status in Metastatic Gastric Cancer: A Retrospective Observational Study, JOURNAL of ONCOLOGICAL SCIENCES, 8(0), 2022 Diğer

Doç. Dr. Mustafa Gürbüz, İzzet Doğan, Erman Akkuş, İbrahim Karadağ, Serdar Karakaya

The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148(6), 2022 SCI / SCI EXPANDED

Mutlu Hızal, Burak Bilgin, Nail Paksoy, Özgür Açıkgöz, Ahmet Sezer

Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC, MEDICINE, 101(0), 2022 SCI / SCI EXPANDED

İzzet Doğan, Doç. Dr. Mustafa Gürbüz, Nail Paksoy, Ferhat Ferhatoğlu, Sezai Vatansever

Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group, Journal of Gastric Cancer, 53(0), 2022 ESCI

Doç. Dr. Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray

The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer, Tuberkuloz ve Toraks-Tuberculosis and Thorax, 70(0), 2022 ESCI

Doç. Dr. Mustafa Gürbüz, İzzet Doğan, Erman Akkuş, Hilal Özakıncı, Pınar Kubilay Tolunay

Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥75) patients, Journal of Mens Health, 17(0), 2021 SCI / SCI EXPANDED

Ali Alkan, Zeynep Gülsüm Güç, Doç. Dr. Mustafa Gürbüz, Güliz Özgün, Serkan Değirmencioğlu

Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 147(0), 2021 SCI / SCI EXPANDED

Burak Bilgin, Mehmet Ali Nahit Sendur, Sebnem Yucel, Emir Celik, Deniz Tataroglu Ozyukseler

Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data, journal of buon, 26(0), 2021 Diğer

Öztürk Ateş, Ömür Berna Öksüzoğlu, Burak Yasin Aktaş, İbrahim Karadağ, Selin Esen

Seasonal Influenza and Pneumococcal Vaccination Rates Among Patients with Cancer in COVID-19 Pandemic: A Cross-Sectional Study, JOURNAL of ONCOLOGICAL SCIENCES, 7(0), 2021 ULAKBİM TR DİZİN

Emre Yekedüz, Elif Berna Köksoy, Satı Coşkun Yazgan, Ilgın Akbıyık, Sevinç Ballı

Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer, Tumori Journal, 107(0), 2021 SCI / SCI EXPANDED

Doç. Dr. Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray

Association Between Blood Type and Epidermal Growth Factor Receptor Mutation Positivity in Lung Adenocarcinoma Patients, JOURNAL of ONCOLOGICAL SCIENCES, 7(0), 2021 ULAKBİM TR DİZİN

Doç. Dr. Mustafa Gürbüz, Erman Akkuş, Bilgin Karaalioğlu, Elif Gizem Aktaş, Elif Berna Köksoy

Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data, Dermatologic Therapy, 34(0), 2021 SCI / SCI EXPANDED

Doç. Dr. Mustafa Gürbüz, İzzet Doğan, Erman Akkuş, Hande Ermiş, Güngör Utkan

Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG), EUROPEAN JOURNAL OF CANCER CARE, 29(0), 2020 SCI / SCI EXPANDED

Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç, Doç. Dr. Mustafa Gürbüz, Tuğba Başoğlu

Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: A case report, JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 27(0), 2020 SCI / SCI EXPANDED

Doç. Dr. Mustafa Gürbüz, Erman Akkuş, Güngör Utkan

Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey, jbuon, 25(4), 2020 Diğer

Muhammet Bekir Hacıoğlu, Osman Kostek, Senem Karabulut, Didem Tastekin, Sema Sezgin Goksu

PROSTAT KANSERİNDE ANDROJEN RESEPTÖR VARYASYONUNUN (AR-V7) KLİNİK ÖNEMİ

XII. Ulusal Haseki Tıp Kongresi · 01.09.2022

Doç. Dr. Mustafa Gürbüz, Yaşar Sertdemir, Emine Kılıç Bağır, Şeyda Erdoğan, Berksoy Şahin

MİDE VE GASTROÖZOFAGEAL BİLEŞKE KANSERLERİNDE PERİOPERATİF FLOT KEMOTERAPİSİ TEK MERKEZ DENEYİMİ

1. ÇUKUROVA İÇ HASTALIKLARI GÜNLERİ · 27.05.2022

Doç. Dr. Mustafa Gürbüz

İLERİ EVRE MİDE KANSERİNDE MULTİDEDEKTÖR BİLGİSAYARLI TOMOGRAFİDE ASİT VARLIĞININ ÖNEMİ

4. ULUSLARARASI TIP BİLİMLERİ VE MULTİDİSİPLİNER YAKLAŞIMLAR KONGRESİ · 26.03.2022

Doç. Dr. Mustafa Gürbüz, Özlem Akıncı

PDL-1 TESTİ YAPILAN KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERLİLERİN (KHDAK) ÇOK MERKEZLİ TÜRKİYE GERÇEK YAŞAM KLİNİK SONUÇLARI

8. Türk Tıbbi Onkoloji Kongresi · 03.11.2021

Ozan Yazıcı, Fatih Gürler, Ramazan Acar, Doç. Dr. Mustafa Gürbüz, Deniz Can Güven

KANSER HASTALARINDA HBV, HCV, HİV SIKLIĞI İLİŞKİLİ FAKTÖRLERİN SAPTANMASI

TÜRK TIBBİ ONKOLOJİ DERNEĞİ SANAL KONGRESİ · 12.11.2020

Doç. Dr. Mustafa Gürbüz, Deniz Tural, Timuçin Çil, Hacer Demir, Osman Köstek

KASTRASYON DİRENÇLİ PROSTAT KANSERİNDE KABAZİTAKSEL: TEK MERKEZ DENEYİMİ

3. Muğla Multidisipliner Onkolojik Araştırmalar Kongresi · 18.10.2019

Doç. Dr. Mustafa Gürbüz, Erman Akkuş, Yüksel Ürün

Colchicine and serum CA72-4 elevation

10th Eurasian Hematology Oncology Congress · 08.10.2019

Doç. Dr. Mustafa Gürbüz, Durmuş Eralp Tutar, Pınar Kubilay Tolunay, Bilgin Karaalioğlu, Emre Yekedüz

Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik (≥75 Yaş) Hastalarda 1. Basamak Dosetaksel Tedavi Sonuçlari- Gerçek Yaşam Verisi

23. Ulusal Kanser Kongresi · 17.04.2019

Ali Alkan, Zeynep Sevgen Güç, Doç. Dr. Mustafa Gürbüz, Güliz Özgün, Serkan Değirmencioğlu